Drug recall D-181-2013
Product
ABILIFY (aripiprazole) Tablets, 30 mg, Rx only, Blister Pack of 100 tablets, Otsuka America Pharmaceutical Inc., Bristol-Myers Squibb NDC 59148-011-35
Reason for recall
CGMP Deviations: A drum of Abilify 30 mg Tablets rejected during the compression stage was not segregated from the other portion of the lot and was inadvertently shipped, packaged and distributed.
Lots and codes
2E69023A, Exp. FEB 28 2015
Recall details
- Recalling firm
- Bristol Myers Squibb Manufacturing Company, Humacao, PR
- Quantity
- 21 blister packs
- Distribution
- LA, TN, CA
- Type
- Voluntary: Firm initiated
- Recall initiated
- November 2, 2012
- Terminated
- May 2, 2013
Related products
- Abilify – drug information
- NDC 59148-006 Abilify · Aripiprazole 2 mg/1 · Otsuka America Pharmaceutical, Inc.
- NDC 59148-008 Abilify · Aripiprazole 10 mg/1 · Otsuka America Pharmaceutical, Inc.
- NDC 59148-010 Abilify · Aripiprazole 20 mg/1 · Otsuka America Pharmaceutical, Inc.
- NDC 59148-009 Abilify · Aripiprazole 15 mg/1 · Otsuka America Pharmaceutical, Inc.
- NDC 59148-007 Abilify · Aripiprazole 5 mg/1 · Otsuka America Pharmaceutical, Inc.
- NDC 59148-011 Abilify · Aripiprazole 30 mg/1 · Otsuka America Pharmaceutical, Inc.